Mpox News and Research

Latest Mpox News and Research

Study reveals poxvirus's unique DNA clamp for gene activation

A research team at the University of Würzburg has deciphered another aspect of poxviral gene activation.

18 Feb 2026

Study reveals evidence of silent mpox exposure in healthy Nigerians

New evidence suggests that mpox may be circulating quietly among healthy Nigerians, with some infections occurring without the symptoms that typically trigger detection by health authorities.

5 Feb 2026

WHO launches 2026 global appeal to ensure millions living in crises and conflicts can access health care

The World Health Organization (WHO) today launched its 2026 global appeal to ensure that millions of people living in humanitarian crises and conflicts can access health care.

4 Feb 2026

Six years after COVID-19: Lessons learned and pandemic preparedness

Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease (later known as COVID-19) a Public Health Emergency of International Concern (PHEIC).

3 Feb 2026

The challenge of tracking asymptomatic Mpox

The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically associated with the disease, according to new research led by scientists from the University of Cambridge and partners in Nigeria. The findings may have implications for controlling the spread of the disease.

20 Jan 2026

Mpox clade Ib transmitted in a healthcare setting outside Africa

Mpox is a viral disease usually transmitted from animals to humans and symptoms include fever and skin rashes. In 2023, a new variant of monkeypox virus (MPXV), called clade Ib, emerged in Kamituga in the Democratic Republic of the Congo.

19 Dec 2025

Climate shocks creating new pathways for disease across Africa

Climate shocks are reshaping ecosystems, creating new pathways for disease across Africa, writes Albert Ansah.

15 Dec 2025

AI helps researchers to find a new way to fight the monkeypox virus

With the help of artificial intelligence, an international team of researchers has made the first major inroad to date towards a new and more effective way to fight the monkeypox virus (MPXV), which causes a painful and sometimes deadly disease that can be especially dangerous for children, pregnant women and immunocompromised people.

10 Dec 2025

Study explains why mpox cases can appear weeks after exposure

Mpox virus clade Ib shows a longer and more variable incubation period than previously characterized clades, with symptom onset extending well beyond 21 days in a substantial minority of cases. Incubation varies by transmission route, with shorter intervals after sexual exposure and longer periods following nonsexual community transmission, raising implications for surveillance and postexposure guidance.

9 Dec 2025

Louisiana took months to sound alarm after two babies died in whooping cough outbreak

When there's an outbreak of a vaccine-preventable disease, state health officials typically take certain steps to alert residents and issue public updates about the growing threat.

4 Nov 2025

Lessons from COVID-19 could help communities better prepare for the next pandemic

The COVID-19 pandemic has provided researchers with a wealth of information on contemporary successes and failures in combating an emerging pathogen.

28 Oct 2025

New epimodulation approach improves outbreak forecasts

During an epidemic, some of the most critical questions for healthcare decision-makers are the hardest ones to answer: When will the epidemic peak, how many people will need treatment at once and how long will that peak level of demand for care last? Timely answers can help hospital administrators, community leaders and clinics decide how to deploy staff and other resources most effectively.

24 Oct 2025

WHO launches EIOS 2.0 to accelerate detection and response to public health threats

Today, the World Health Organization (WHO), in collaboration with key partners and supporters, launched version 2.0 of the Epidemic Intelligence from Open Sources (EIOS) system, used globally for the early detection of public health threats.

14 Oct 2025

AI combined with the One Health approach can improve pandemic preparedness

Artificial intelligence could be a valuable tool for detecting emerging diseases earlier, researchers from five European universities and research institutes argue in The Lancet Infectious Diseases.

3 Oct 2025

Global Virus Network accelerates mpox diagnostic research

With global attention shifting away from mpox after recent declines in case counts, the Global Virus Network (GVN) is warning against complacency and urges accelerating efforts to strengthen outbreak readiness.

25 Sep 2025

Rwanda confronts a surprising surge in malaria

After years of progress in reducing malaria cases, Rwanda is confronting a surprising resurgence and signs of treatment resistance that have forced officials to revisit vaccine intervention the country once declined.

15 Sep 2025

Yale scientists boost mRNA vaccine power with new technology

Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their highly effective vaccines to fight the virus.

27 Aug 2025

Novel monoclonal antibodies show promise in preventing severe mpox disease

A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox (formerly known as monkeypox).

26 Aug 2025

AI and wastewater surveillance unite to detect emerging viruses

Wastewater surveillance became a popular choice among public health officials looking to track rapid virus mutations and spread patterns during the COVID-19 pandemic.

21 Jul 2025

New WHO guidelines recommend injectable lenacapavir for HIV prevention

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response.

14 Jul 2025